Bulletin
Investor Alert

Edesa Biotech Inc.

NAS: EDSA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Sep 30, 2022, 7:52 p.m.

/zigman2/quotes/200172674/composite

$

0.86

Change

-0.06 -6.65%

Volume

Volume 133,854

Quotes are delayed by 20 min

/zigman2/quotes/200172674/composite

Previous close

$ 1.42

$ 0.92

Change

-0.50 -35.12%

Day low

Day high

$0.90

$1.65

Open

52 week low

52 week high

$0.90

$8.95

Open

Lorin K. Johnson

Founder of Salix Pharmaceuticals Ltd. and Glycyx PharmaVentures Ltd., Lorin K. Johnson is Chief Scientist at Glycyx PharmaVentures Ltd. and on the board of 8 other companies.

In the past Dr. Johnson was Chief Scientific Officer & Senior Vice President at Salix Pharmaceuticals Ltd., Chief Scientist & Director-Scientific Operations at Scios, Inc., Chief Scientist & Director-Scientific Operations at California Biotechnology, Inc., Assistant Professor-Pathology at The University of California, San Francisco and Assistant Professor-Pathology at Stanford University School of Medicine.

Lorin K. Johnson received a doctorate from the University of Southern California.

Transactions

Date Shares Transaction Value
11/09/2020 4,262   17,048
11/09/2020 4,262   17,048
01/08/2020 8,524   35,033
01/08/2020 8,524   Award at $4.11 per share. 35,033
01/08/2020 8,524   Acquisition at $4.11 per share. 35,033
06/07/2019 0   0

Officers and Executives

Dr. Pardeep Nijhawan
Chief Executive Officer, Secretary & Director
Dr. Michael Brooks
President
Ms. Kathi Niffenegger
Chief Financial Officer
Dr. Blair Gordon
Vice President-Research & Development
Mr. Rajan Puri
Senior Vice President-Manufacturing
Mr. Frank R. Oakes
Director
Ms. Jennifer M. Chao
Director
Mr. Gary Koppenjan
Vice President-Investor Relations & Communications
Mr. Sean A. MacDonald
Chairman
Dr. Lorin K. Johnson
Independent Director
Mr. Paul William Pay
Independent Director
Mr. Carlo Sistilli
Independent Director
Link to MarketWatch's Slice.